openPR Logo
Press release

Biologic Injectors Market Insights, Forecast to 2028

02-15-2019 09:53 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR

Biologic injectors are the injecting devices used to deliver drugs and other substances for biological purposes. Biological products such as drugs, growth hormones, antibodies and other complex biological molecules are administered into the body of an organism through biologic injectors. Biologic injectors are basically used for the treatment of various diseases.

Biologic injectors offer different methods of administration such as simple piston, gas, jet and others. They can also be used for the storage or handling of biological molecules. Accurate dosing is one the most important advantages offered by biologic injectors. Thus, the risk of overdose of a drug is significantly reduced with the use of biologic injectors, which is considered as a major advantage of biologics injectors. Biologic injectors can be used for the delivery of general drug or any drug of a specific product line. They can be used for the administration of single doses or multiple doses and the dosage of the drug can be adjusted by the user.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2288

Biologic Injectors Market: Drivers and Restraints

The increasing demand for drug delivery is expected to be the major factor driving the growth of the biologic injectors market over the forecast period. The introduction of disposable and reusable biologic injectors is expected to drive the growth of the biologic injectors market. The incidences of cancer, brain diseases and heart diseases are increasing, which is significantly driving the growth of the biologic injectors market .This in turn is expected to increase the revenue share of the biologic injectors market. Biologic injectors are associated with the accurate dosing of drugs and prevention of sharp injuries.

On the other hand, the difficulties associated with the delivery of highly viscous drugs can restrain the biologic injectors market .Other factors such as risk of infection at the site of administration may also hinder the growth of the biologic injectors market.

Biologic Injectors Market: Segmentation

Tentatively, the global biologic injectors market can be segmented on the basis of treatment, indication, distribution channel and geography.

Based on application, the global biologic injectors market has been segmented as:

Oncology
Cardiology
Autoimmune
Pain management
Others
Based on distribution channel, the global biologic injectors market has been segmented as:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Others
Ask For Customized Report @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=2288

Biologic Injectors Market: Overview

The global market for biologic injectors is expected to witness moderate growth over the forecast period. Biologic injectors find a vast range of applications such as oncology, cardiology, autoimmune disorders and many others. Based on distribution channel, the biologic injectors market has been segmented into hospitals, pharmacies and various other drug stores. Drug delivery is one of the main applications where biologic injectors play an important role.

Biologic Injectors Market: Regional Outlook

On the basis of geography, the global biologic injectors market has been segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant region in the global biologic injectors market, owing to advancements in healthcare technologies in the region. Europe is expected to hold the second large share in the global biologic injectors market throughout the forecast period.

Biologic Injectors Market: Market Participants

The global market for biologic injectors is highly fragmented. Examples of some of the key players operating in the global biologic injectors market are Roche, Abbott, Schott, Nipro, Ompi, Becton and Dickinson & Co., Bayer AG, Pfizer, Inc., Bristol-Myer Squibb, Novartis International AG, Novartis AG and others.

For more information on this report, please visit:https://www.factmr.com/report/2288/biologic-injectors-market

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/

Read Industrial News : http://insiderstribune.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biologic Injectors Market Insights, Forecast to 2028 here

News-ID: 1591369 • Views:

More Releases from Fact.MR

Mechanically Separated Poultry Market Is Projected To A Colossal $255.9 Million By 2034
07-19-2024 | Food & Beverage
Fact.MR
Mechanically Separated Poultry Market Is Projected To A Colossal $255.9 Million …
It is anticipated that the global mechanically separated poultry market would reach US$ 160.4 million by 2024. By the end of 2034, the mechanically separated poultry market is expected to grow at a 4.8% CAGR and be worth US$ 255.9 million worldwide. The mechanically separated poultry (MSP) market has seen consistent growth over recent years, driven by increasing demand for cost-effective meat products and advancements in food processing technologies. This
Glucose Management Supplement Market Is Expected To A Colossal $17.5 Billion By 2034
07-19-2024 | Food & Beverage
Fact.MR
Glucose Management Supplement Market Is Expected To A Colossal $17.5 Billion By …
The estimated worth of the global glucose management supplement market is expected to rise from US$ 9.7 billion in 2024 to US$ 17.5 billion by the end of 2034. It is true.Sales of glucose management supplements are expected to increase at a compound annual growth rate (CAGR) of 6.1% between 2024 and 2034, according to MR's most recent analysis. The glucose management supplement market has seen significant growth in recent years,
Rosehip Market Is Expanding Estimated To A Colossal $486.7 Million By 2034
07-19-2024 | Food & Beverage
Fact.MR
Rosehip Market Is Expanding Estimated To A Colossal $486.7 Million By 2034
The revenue from the global rosehip market is expected to grow at a 5.6% CAGR from 2024 to 2034, from a value of US$ 282.6 million in 2024 to US$ 486.7 million by the end of that year. The Rosaceae family includes the herbal medicine made from rosehips. This wild rose variety, also called Rosa canina, grows well in many parts of Asia, Africa, and Europe. After fertilization, rosehips, the
Banana Blossoms Market Is Expanding Set To A Reach $344 Million By 2034
07-19-2024 | Food & Beverage
Fact.MR
Banana Blossoms Market Is Expanding Set To A Reach $344 Million By 2034
The global banana blossoms market is expected to generate US$ 179.8 million in sales in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 6.7% to US$ 344 million by the end of 2034. Because banana blossoms taste so good and have so many health benefits, the global market for them is expanding. Banana blossoms, sometimes referred to as "banana hearts," are plump purple-skinned flowers

All 5 Releases


More Releases for Biologic

Nerve Biologic Products Market - Advancements in research and development for de …
The report presents an in-depth assessment of the Nerve Biologic Products Market including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles, and strategies. The report profiles the key players in the industry, along with a detailed analysis of their individual positions against the global landscape. The study conducts SWOT analysis to evaluate strengths and weaknesses
Biologic Microscope Market Global Insights and Demand 2020
Global Biologic Microscope Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Biologic Microscope Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes
Biologic Therapeutics Market Insights & Outlook on Industry 2025
Global Biologic Therapeutics Market: Snapshot The branch of science that deals with manufacturing medicines and pharmaceutical products based on biological origins is called biological therapeutics. Any pharmaceutical drug product manufactured from semi-synthesized and biological sources is included under this field. Owing to rapid advances experienced by this sector, a distinct biologic therapeutics market has formed. This market is mainly being driven by a rising demand for better healthcare treatments occurring all
Biologic Therapeutics Market Geographical Outlook by 2025
Global Biologic Therapeutics Market: Overview The global biologic therapeutics market is predicted to benefit from the rising applications of biological products. Biological products could be made of sugars, nucleic acids, proteins, or complex combinations of these substances, or may be living components such as cells and tissues. Biological products are used to prevent diseases, diagnose diseases, or treat or cure medical conditions. Global Biologic Therapeutics Market: Key Trends and Opportunities First and foremost,
Human Hepatitis B Immunoglobulin (IM) Market 2017 - Shanghai RAAS, Hualan Biolog …
Apex Research, recently published a detailed market research study focused on the "Human Hepatitis B Immunoglobulin (IM) Market" across the global, regional and country level. The report provides 360° analysis of "Human Hepatitis B Immunoglobulin (IM) Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Human Hepatitis B Immunoglobulin (IM) industry, and
Global Biologic Drugs Sales Market Report 2017
In this report, the global Biologic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Biologic Drugs for these regions, from 2012 to 2022 (forecast),